Clinical Pharmacology Study of Oral Edaravone in Amyotrophic Lateral Sclerosis Patients With Gastrostomy
Abroad (travel likely)CompletedPHASE1
Conditions
Japanese Patients With ALS
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Investigational site, Chiba, Japan
Study leads
General Manager
Study Director
Tanabe Pharma Corporation
View source on ClinicalTrials.gov(opens in a new tab)
No study contact email or phone is listed for this trial.